05:40 PM EDT, 04/15/2026 (MT Newswires) -- Wave Life Sciences ( WVE ) said late Wednesday its board has unanimously approved a plan to redomicile its parent company from Singapore to the United States.

Subject to receiving necessary shareholder and Singapore High Court approvals, the ordinary shares of the existing Singapore parent company will be exchanged on a one-for-one basis for common stock in a newly-formed Delaware parent corporation, Wave Life Sciences, Inc, according to the company.

Upon completion of the redomiciliation, the shares of the new Delaware parent corporation will continue to trade on Nasdaq under the existing trading symbol "WVE".

Wave expects the redomiciliation to take effect in mid-2026, and it is expected to be tax-free for US shareholders.